Inhibitory PAS (Per/Arnt/Sim) domain protein (IPAS) is a dominant negative transcription factor that represses hypoxia-inducible factor 1 (HIF-1) activity. In this study, we show that IPAS also functions as a pro-apoptotic protein through binding to pro-survival Bcl-2 family members. In a previous paper, we reported that NF-jB-dependent IPAS induction by cobalt chloride repressed the hypoxic response in PC12 cells. We found that prolonged incubation under the same conditions caused apoptosis in PC12 cells. Repression of IPAS induction protected cells from apoptosis. Furthermore, knockdown of IPAS recovered cell viability. EGFP-IPAS protein was localized in both the nucleus and the cytoplasm, with a large fraction associated with mitochondria. Mitochondrial IPAS induced mitochondria depolarization and caspase-3 activation. Immunoprecipitation assays revealed that IPAS is associated with Bcl-x L , Bcl-w and Mcl-1. The association of IPAS with Bcl-x L was also observed in living cells by the FLIM-based FRET analysis, indicating direct binding between the two proteins. IPAS contributed to dysfunction of Bcl-x L by inhibiting the interaction of Bcl-x L with Bax. These results demonstrate that IPAS functions as a dual function protein involved in transcription repression and apoptosis.
Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that functions as a master regulator of gene expression in response to hypoxia.
1-3 HIF-1 consists of an oxygenregulated HIF-1a subunit and a constitutively expressed Arnt (HIF-1b) subunit. In normoxia, HIF-1a is rapidly degraded by the ubiquitin-proteasome system. On the other hand, in hypoxia, HIF-1 is stabilized, translocated into the nucleus and bound to hypoxia-response element (HRE) to induce downstream gene expression of hypoxia-responsive proteins, such as erythropoietin, vascular endothelial growth factor and tyrosine hydroxylase. The inhibitory PAS (Per/Arnt/Sim) domain protein (IPAS), one of the alternatively spliced variants of HIF-3a, functions as a dominant negative inhibitor of HIF-1. 4 IPAS directly interacts with HIF-1a and HIF-1a-like factor (HLF, also known as HIF-2a or EPAS1) and prevents their dimerization with Arnt and subsequent DNA binding. IPAS is predominantly expressed in the Purkinje cells of the cerebellum and corneal epithelium. In addition, it is reported that IPAS is induced by hypoxia in the heart and lung through activation of HIF-1. 5 Thus, IPAS functions as a negative feedback inhibitor of HIF-dependent hypoxic response.
Hypoxic cell death can be mediated by HIF-1. 6 It can induce apoptosis through activation of BNIP3 and Noxa, which were identified as HIF-1-responsive pro-apoptotic proteins. 7, 8 However, HIF-1 also functions to prevent cell death and even stimulate cell proliferation. 9 Constitutive HIF-1 stabilization is observed in many types of cancers, in which it is associated with resistance to hypoxic apoptosis. 9 Recent papers have shown that some anti-apoptotic molecules are identified as HIF-1 targets, such as Bcl-x L and Mcl-1. 10, 11 Although it is considered that a delicate balance determines cell fate between self-killing of cells by apoptosis via induction of pro-apoptotic factors and adaptation of cells to the hypoxic environment through induction of anti-apoptotic factors and cell growth-related proteins, the complex roles of HIF-1 in cell death and cell survival are not fully understood and remain to be elucidated.
Hypoxic cell death is influenced by the presence of reactive oxygen species (ROS). ROS are known to accumulate after ischemic/hypoxic reoxygenation or intermittent hypoxia leading to extensive cell death. 12, 13 This situation is observed in several pathophysiological conditions such as cerebral and myocardial infarction. 13, 14 Although the role of ROS in cell death is not well understood, they can attack and oxidize nucleic acids, proteins and lipids, resulting in neuronal apoptosis. 13, 15 Rat pheochromocytoma-derived PC12 cells are widely used as in vitro model cells for investigating neuronal apoptosis in hypoxia/ischemic conditions. [16] [17] [18] [19] There are several reports showing that cobalt chloride (CoCl 2 ) or nitric oxide could mimic hypoxia/ischemic conditions, including generation of ROS, and induces mitochondria damage and apoptosis. [16] [17] [18] [19] [20] Recent reports have shown that CoCl 2 -induced ROS leads to accumulation of HIF-1a in many mammalian cells, including PC12 cells. [21] [22] [23] Moreover, our recent report showed that CoCl 2 -induced ROS also upregulates the expression of IPAS mRNA through NF-kB activation in PC12 cells. 23 Although there is increasing evidence suggesting a close relationship between hypoxic cell death and ROS generation in hypoxia as described above, the underlying mechanism linking them is not fully understood. Our analyses here demonstrate that IPAS functions as a pro-apoptotic factor acting in the mitochondria, although it is also localized in the nucleus. We also show that IPAS directly interacted with pro-survival Bcl-2 family members, such as Bcl-x L , and this binding led to dysfunction of Bcl-x L by blocking its anti-apoptotic activity to bind to Bax. These results demonstrate that IPAS functions as a dual function protein involved in gene regulation in response to hypoxia and hypoxic apoptosis.
Results
Apoptosis induced by CoCl 2 in RPMI-cultured PC12 cells. To examine CoCl 2 -induced cell death in PC12 cells under different nutritional conditions, PC12 cells were cultured in DMEM or RPMI in the presence of CoCl 2 for 24 h, and cell viability was measured by trypan blue exclusion. Figures 1a and b show that CoCl 2 -induced cell death in PC12 cells occurred when cultured in RPMI medium depending on the concentration of CoCl 2 , but not at all in DMEM. We have previously shown that IPAS was induced by CoCl 2 in PC12 cells when cultured in RPMI but not in DMEM, and that addition of three nutrients, magnesium, histidine and threonine (3Mix) to RPMI abolished the induction. 23 CoCl 2 -induced cell death in PC12 cells found in RPMI medium was similarly blocked by the addition of 3Mix (Figures 1a and b) . Hereafter 150 mM CoCl 2 was used to induce cell death because of its potent effect. To determine 
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Pro-apoptotic activity of IPAS S Torii et al whether CoCl 2 -induced cell death of RPMI-cultured PC12 cells had the characteristics of apoptosis, we carried out DNA fragmentation assay and nuclear staining with Hoechst 33342. DNA fragmentation assay showed that a clear DNA ladder was observed 16 h after exposure of PC12 cells to CoCl 2 (Figure 1c ) only when cultured in RPMI. Nuclear condensation was detected in CoCl 2 -treated PC12 cells when cultured in RPMI, but not in DMEM or RPMI with 3Mix ( Figure 1d ). In addition, Annexin-V/propidium iodide (PI) staining showed that CoCl 2 induced apoptosis rather than necrosis, and this cell death was inhibited by a caspase inhibitor, Z-VAD-FMK (Figure 1e) . Furthermore, release of mitochondrial cytochrome c and activation of caspase-3 were observed in CoCl 2 -treated PC12 cells when cultured in RPMI (Figures 1f-h ).
Induction of IPAS in RPMI-cultured PC12 cells and its role in induction of apoptosis. We have already shown that IPAS expression was significantly induced in response to CoCl 2 only when PC12 cells were cultured in RPMI (Figure 2a) . 23 Therefore, we hypothesized that IPAS was one of the causal factors in CoCl 2 -induced apoptosis in RPMIcultured PC12 cells, and we investigated this possibility by the treatment of PC12 cells with siRNA for IPAS. We have already shown that the endogenous IPAS mRNA level was decreased by IPAS/HIF-3a siRNA treatment (Figure 2b ). 23 Downregulation of HIF-3a expression by the treatment was hardly detectable as it was very weakly expressed ( Figure 2b ). In addition, ectopic expression of Myc-tagged mouse IPAS was greatly decreased following IPAS/HIF-3a siRNA treatment (Figure 2c ). IPAS/HIF-3a siRNA treatment Figure 4d) , suggesting that the distance between the N-termini of IPAS and Bcl-x L is longer than that of the C-termini. These results demonstrate that the IPAS C-terminal domain directly binds to Bcl-x L and strongly suggest that it can trigger a series of events leading to activation of apoptosis. To confirm this possibility, we examined whether the interaction of IPAS with Bcl-x L inhibits the function of Bcl-x L to bind to Bax. Immunoprecipitation assays showed that IPAS inhibited the interaction of Bcl-x L with Bax by 60% (Figure 8a ). We examined localization of endogenous Bax in PC12 cells treated with CoCl 2 . Figure 8b shows that Bax is predominantly cytosolic in resting cells and translocates into membrane fractions in response to CoCl 2 treatment. Furthermore, we examined the effect of IPAS/HIF-3a siRNA treatment on binding of Bcl-x L with Bax in PC12 cells. Figure 8c shows that Bcl-x L formed a complex with Bax in resting cells and stimulation with CoCl 2 resulted in the complete dissociation of the complex. IPAS/HIF-3a siRNA treatment inhibited this dissociation, suggesting that endogenous IPAS enhanced the dissociation of Bcl-x L /Bax complex in CoCl 2 -treated cells. Finally, we examined whether ectopic expression of Bcl-x L inhibits IPAS-mediated activation of caspase-3. As shown in Figure 8d , Bcl-x L strongly inhibited the activation of caspase-3. Bcl-2 inhibited this activation to some extent, probably because Bcl-2 weakly bound to IPAS and/or strongly bound to free Bax. Binding of IPAS to HIF-1a and HLF. IPAS was originally identified as a negative regulator of HIF-1-mediated hypoxic response and is reported to directly bind to HIF-1a and HLF. 4 We examined whether our IPAS constructs bind to HIF-1a and HLF. As expected, IPAS WT and IPAS N bound to HIF-1a and HLF in the co-immunoprecipitation assay (Supplementary Figures 5a and 6a) . IPAS C also interacted with HIF-1a and HLF, with an intensity similar to IPAS N. When co-expressed with HIF-1a or HLF, most of the IPAS WT was colocalized with HIF-1a and HLF in the nucleus, particularly in the nuclear speckles ( Supplementary  Figures 5b and 6b) . Similar colocalization of IPAS N with HIF-1a and HLF was observed in the nuclear speckles. Unexpectedly, HIF-1a and HLF were colocalized with IPAS C in the clusters of mitochondria. Binding affinity between IPAS WT and HIF-1a was compared with that between IPAS WT and Bcl-x L . IPAS WT bound to both Bcl-x L and HIF-1a, suggesting that similar affinity was present between the two interactions (Supplementary Figure 7) . On the other hand, binding of IPAS C to HIF-1a was not observed when Bcl-x L was co-expressed. Similar results were obtained when HLF was used instead of HIF-1a. These results demonstrate that IPAS binds to HIF-1a and HLF using both the N-terminal and C-terminal regions and that the C-terminal region of IPAS has two functional regions. One acts as a region for binding to Bcl-x L and the other a region for binding to HIF-1a and HLF.
Discussion
Helix-loop-helix and PAS A domains that function as dimerization domains are localized in the N-terminal region of IPAS. On the other hand, no noticeable domains were reported in the C-terminal region. We determined that a specific sequence that is involved in the induction of apoptosis is localized in the C-terminal region, especially in the most C-terminal part. C-terminal 67 amino acids used for IPAS C2 constructs are encoded by exon 16 (final exon) and this exon is not used in other splicing variants of HIF-3a, 5 suggesting that other splicing variants may have no pro-apoptotic activity. Figure 8e shows our present model for the action of IPAS on apoptosis. IPAS was able to bind to some of pro-survival Bcl-2 members, such as Bcl-x L through the C-terminal region on the mitochondria and may block the interaction between Bcl-x L and Bax, thus activating a Bax-dependent apoptotic cascade, followed by release of cytochrome c and activation of caspase-3. This study shows that the C-terminal region of IPAS is responsible for binding to Bcl-x L . Observations that interaction between Bcl-x L and Bax was decreased by overexpression of IPAS and increased by knockdown of IPAS support the model (Figures 8a and c) . Finding that endogenous Bax was translocated to membrane fractions in response to CoCl 2 treatment (Figure 8b ) also supports the model. The mode of action of IPAS is reminiscent of BH3 only proteins. We surveyed sequences analogous to the BH3 domain within the C-terminal region, and found a region with very weak similarity to the BH3 domain. However, introduction of point mutations in the sequence did not inhibit the binding to Bcl-x L , suggesting that the binding mode of IPAS to pro-survival Bcl-2 members may be different from that of BH3 only proteins. Though we focused on the interaction of Bcl-x L with Bax, Bcl-x L is also known to bind to and inhibit activation of Apaf-1, a transmitter of apoptotic signals from mitochondrial damage to activate caspases. 24 IPAS may also inhibit binding of Bcl-x L to Apaf-1 and other interacting proteins. Bcl-x L is critical for the survival of immature neurons, whereas Bax and Apaf-1 are crucial for neuronal cell death in the nervous system. 25 Therefore, the functions of IPAS associated with these proteins may be important for neuronal cell death in vivo. We observed that IPAS was induced in the brain including substantia nigra and locus ceruleus in response to CoCl 2 , suggesting that IPAS expression may be related to neuronal cell death occurring in Parkinson's disease and other neurodegenerative diseases. ROS seems to contain the driving force for neurodegeneration in Parkinson's disease. 15, 26 It is known that IPAS is predominantly expressed in the Purkinje cells of the cerebellum. 4 However, it seems that these cells, despite IPAS expression, do not undergo apoptosis. One possible reason is that post-translational modification of IPAS occurs to avoid cell death in these cells. Although evidence for the modification of IPAS is presently not found, there are multiple consensus phosphorylation sites recognized by signal-regulated protein kinases in the IPAS sequence. This study demonstrates that IPAS was localized in nucleus rather than cytoplasm in HEK293T cells, and almost all IPAS was translocated to the nucleus when expressed with HIF-1a and HLF. Possible inhibitory proteins that interact with IPAS may forcibly sequester IPAS in the nucleus or other organelles to suppress its pro-apoptotic activity.
We confirmed that IPAS forms a complex with HIF-1a and HLF. The N-terminal region of IPAS exhibited binding activity to HIF-1a and HLF. It is plausible to assume that this association occurs through the bHLH (basic helix-loop-helix) and PAS domains present in the N-terminal region since the domains are used for a common dimerization interface in bHLH-PAS proteins. However, association of the C-terminal region with HIF-1a and HLF was unexpected. We believe that HIF-1a and HLF were accumulated in the mitochondria through a part of the IPAS C-terminal region ( Supplementary  Figures 6 and 7) . Known-sequence motifs serving as protein interaction were not found in the region by a computer database search. It is necessary to delineate the regions that contributed to the binding in both the IPAS C-terminal region and the HIF-1a/HLF sequences.
Molecular mechanisms for switching from transcription factor to pro-apoptotic protein and vice versa are presently unknown, and elucidation of the mechanism will be needed for understanding of ROS-induced cell death.
Materials and Methods
Cell culture and DNA transfection. PC12 cells, HEK293T cells and CHO-K1 cells were obtained from the Cell Resource Center for Biomedical Research, Tohoku University, Sendai, Japan. PC12 cells were maintained in Pro-apoptotic activity of IPAS S Torii et al RPMI-1640 (Wako Pure Chemical Industries, Osaka, Japan) supplemented with 10% fetal bovine serum in collagen IV-coated dishes (BD Biosciences, San Jose, CA, USA) under 5% CO 2 at 37 1C, and transferred every three days. HEK293T cells and CHO-K1 cells were maintained as described. 27 ,28 PC12 and CHO-K1 cells were transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. HEK293T cells were transfected using Lipofectamine 2000 and as described. 27, 29 Cell viability assay with trypan blue dye exclusion. Cell number and viability were determined with a conventional hemocytometer by trypan blue dye exclusion. PC12 cells were plated in 6-well plate at 1.4 Â 10 6 cells per well. After incubation for 24 h, cells were treated with 100 or 150 mM CoCl 2 for 24 h in the indicated medium, and collected with 5 mM EDTA in Hank's balanced salt solution (Invitrogen). Determination of DNA fragmentation. PC12 cells were plated in collagen IV-coated 60 mm dish at 4 Â 10 6 cells per dish. After incubation for 24 h, cells were treated with 150 mM CoCl 2 for 16 h in the indicated medium, collected and lysed in 100 ml of lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM EDTA and 1% Triton X-100). After centrifugation at 1100 Â g for 10 min, DNA was extracted from the supernatant and analyzed by agarose gel electrophoresis.
Nuclear staining with Hoechst 33342. PC12 cells were treated with 150 mM CoCl 2 for 16 h in the indicated medium, stained with Hoechst 33342 for 30 min, fixed in 4% paraformaldehyde-PBS and mounted with Mowiol (Calbiochem, San Diego, CA, USA).
Annexin V/PI staining. Annexin V-FITC Apoptosis detection kit was purchased from B-bridge (San Jose, CA, USA). PC12 cells on glass coverslips were treated with or without 150 mM CoCl 2 for 16 h in the indicated medium. The assays were carried out according to the manufacturer's protocol. Cells were mounted in Mowiol and examined using a fluorescence microscope (Olympus IX71, Olympus, Tokyo, Japan). Caspase inhibitor, Z-VAD-FMK was purchased from Medical Biological Laboratories (Nagoya, Japan).
RT-PCR. PC12 cells were treated with or without 150 mM CoCl 2 for 6 or 10 h in the indicated medium. Total RNA was extracted from cells using RNAiso (Takara Bio, Otsu, Japan). cDNAs were synthesized using oligo random hexamers (Invitrogen) and ReverTra Ace transcriptase (Toyobo, Osaka, Japan). A fraction (1 ml) of synthesized cDNA was amplified in a 20 ml reaction mixture containing 5 units of Ex Taq HS polymerase (Takara Bio). PCR cycles were chosen within the linear range of amplification. The PCR procedure consisted of 16 cycles of reaction for 18 S rRNA cDNA, 35 for IPAS and HIF-3a: 941C for 30 s, 601C for 30 s and 721C for 20 s. The primers used for the reaction were described previously. Molecular cloning and plasmid construction. Mouse IPAS cDNA was kindly provided by Dr. Y. Makino. All IPAS cDNA fragments were prepared by PCR and ligated into pEF-BOS vector containing three Myc tags, pEGFP-C1 vector or pCerulean-C1 vector. The full-length cDNAs of mouse Bcl-2, Bcl-x L , Bcl-w and Bax were synthesized by PCR using mouse brain cDNA derived from C57BL6J as a template. Mouse Mcl-1V and A1a were synthesized using mouse lung cDNA. Mcl-1V is a splicing variant of MCl-1 and lacks 46 amino acids residues within Mcl-1. These cDNAs were ligated into the pEF-BOS vectors containing three Myc, three FLAG or an HA tag. pBOS-FLAG human HIF-1a and pBOS-FLAG mouse HLF were described previously. 30 The full-length cDNAs of HIF-1a and HLF were ligated into the pCitrine-C1 vector. All tags were added to the N-terminus of each protein. For FLIM-FRET analysis, IPAS, IPAS C and Bcl-x L were ligated into the pCerulean-N1 and pCitrine-N1 vector for a C-terminal tag, and pCerulean-C1 and pCitrine-C1 for an N-terminal tag.
Immunostaining. After fixation by 4% paraformaldehyde-PBS solution and permeabilization with 0.5% (or 0.1% for anti-cytochrome c) Triton X-100 in PBS for 5 min, cells were incubated with indicated primary antibodies at room temperature for 1 h, and then with the appropriate secondary antibodies at room temperature for 1 h. Cells were finally mounted in Mowiol and examined using a laser scanning confocal microscope (Olympus FV300) or a fluorescence microscope (Olympus IX71). An antibody against cytochrome c and active-caspase-3 was purchased from BD Pharmingen (San Jose, CA, USA) and Promega (Fitchburg, WI, USA), respectively. In PI staining, cells were treated by 100 mg/ml RNase at 371C for 20 min after fixation by 4% paraformaldehyde-PBS solution, and incubated by 400 ng/ml PI for 10 min.
Determination of mitochondrial transmembrane potential with JC-1. PC12 cells were transfected with indicated constructs and treated with Z-VAD-FMK. 24 h after transfection, cells were incubated with JC-1 (Cayman Chemical, Ann Arbor, MI, USA) and Hoechst 33342 for 20 min at 371C, and observed by using a fluorescence microscope (Olympus IX71).
Immunoprecipitation and immunoblotting. Immunoprecipitation assays were carried out as described previously. 31 Cells were lysed in lysis buffer containing 20 mM Hepes (pH7.5), 100 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGDA, 10 mM Na 2 P 2 O 7 , 10% glycerol, 1% Nonidet P-40, 1 mM dithiothreitol, 1 mM Na 3 VO 4 , 1 mM PMSF and 1% Aprotinin (Sigma, St. Louis, MO, USA). For Bax-Bclx L binding assay, cells were lysed in CHAPS buffer (PBS (pH 7.4) containing 10 mM CHAPS, 150 mM NaCl, 1 mM NaF, 10 mM Na-phosphate, 1 mM dithiothreitol, 1 mM Na 3 VO 4 , 1 mM PMSF and 1% Aprotinin) for 1 h on ice and centrifuged at 12 000 Â g. The anti-Bcl-x L antibody was added to the supernatant of the CHAPS lysate and immunoprecipitates were analyzed. Binding reaction mixtures were loaded on 10B13% SDS-polyacrylamide gels. After electrophoresis, the proteins were blotted onto a nitrocellulose membrane (GE Healthcare, Little Chalfont, UK) and probed with indicated first antibodies. Anti-Bcl-2 was purchased from Santa Cruz (Santa Cruz, CA, USA). Anti-Bcl-x L , anti-Bax and anti-caspase-3 antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Anti-Myc and anti-HA antibodies were purchased from Medical Biological Laboratories. Anti-FLAG and anti-b-tubulin was from Sigma. Horseradish peroxidase-linked goat anti-rabbit IgG (Jackson ImmunoReseach, West Grove, PA, USA) was used as the second antibody. The membrane was developed with the ECL Plus detection system (GE Healthcare).
FLIM measurements. FLIM measurements were carried out as described previously. 28 In brief, fluorescence lifetimes of cells were measured on an inverted microscope (Zeiss (Jena, Germany): Axiovert 135, Â 100 oil immersion objective with numerical aperture of 1.3) equipped with a disk anode microchannel plate photomultiplier (Europhoton, Berlin, Germany), which can detect photons in a timeresolved and space-resolved manner by using a time-correlated single-photoncounting technique. Fluorescence from live cell samples incubated at 371C was sequentially collected at 475 ± 25 nm for Cerulean and 575 ± 25 nm for Citrine by bandpass filters at a count rate below about 0.5 counts (pixel Á s)
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. Subcellular fractionation. PC12 cells were lysed in lysis buffer containing 20 mM Hepes (pH7.5), 100 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGDA, 10 mM Na 2 P 2 O 7 , 10% glycerol, 1 mM dithiothreitol, 1 mM Na 3 VO 4 , 1 mM PMSF and 1% Aprotinin. Cell lysates were vortexed for 15 s and centrifuged at 16 000 Â g for 20 min. Pellets contained the enriched mitochondrial fraction, whereas supernatants contained mainly the cytosolic fractions. Pellets were re-lysed into lysis buffer shown above with Nonidet P-40. 20 mg of proteins were analyzed by immunoblotting with antibodies against Bax, Bcl-x L and GAPDH (Trevigen, Gaithersburg, MD, USA). 
